[go: up one dir, main page]

DE69105627D1 - Immunreagenzien reaktiv mit einem konservierten Epitope des humanen Immundefizienzviruses I (HIV-I) GP120 und Verfahren zu deren Verwendung. - Google Patents

Immunreagenzien reaktiv mit einem konservierten Epitope des humanen Immundefizienzviruses I (HIV-I) GP120 und Verfahren zu deren Verwendung.

Info

Publication number
DE69105627D1
DE69105627D1 DE69105627T DE69105627T DE69105627D1 DE 69105627 D1 DE69105627 D1 DE 69105627D1 DE 69105627 T DE69105627 T DE 69105627T DE 69105627 T DE69105627 T DE 69105627T DE 69105627 D1 DE69105627 D1 DE 69105627D1
Authority
DE
Germany
Prior art keywords
immunoreagents
epitope
hiv
reactive
immunodeficiency virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69105627T
Other languages
English (en)
Other versions
DE69105627T2 (de
Inventor
David Da-I Ho
James Edmun Robinson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cedars Sinai Medical Center
Louisiana State University
Original Assignee
Cedars Sinai Medical Center
Louisiana State University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/701,129 external-priority patent/US5798251A/en
Application filed by Cedars Sinai Medical Center, Louisiana State University filed Critical Cedars Sinai Medical Center
Application granted granted Critical
Publication of DE69105627D1 publication Critical patent/DE69105627D1/de
Publication of DE69105627T2 publication Critical patent/DE69105627T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70514—CD4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/461—Igs containing Ig-regions, -domains or -residues form different species
    • C07K16/462—Igs containing a variable region (Fv) from one specie and a constant region (Fc) from another
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C07K2317/732—Antibody-dependent cellular cytotoxicity [ADCC]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • AIDS & HIV (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Gasification And Melting Of Waste (AREA)
  • Devices And Processes Conducted In The Presence Of Fluids And Solid Particles (AREA)
  • Crucibles And Fluidized-Bed Furnaces (AREA)
  • Fluidized-Bed Combustion And Resonant Combustion (AREA)
DE69105627T 1990-05-29 1991-05-29 Immunreagenzien reaktiv mit einem konservierten Epitope des humanen Immundefizienzviruses I (HIV-I) GP120 und Verfahren zu deren Verwendung. Expired - Fee Related DE69105627T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53085090A 1990-05-29 1990-05-29
US07/701,129 US5798251A (en) 1990-05-29 1991-05-16 Antibody and antibody derivative immunoreagents reactive with a conserved epitope of Human Immunodeficiency Virus Type 1 (HIV-1) gp 120

Publications (2)

Publication Number Publication Date
DE69105627D1 true DE69105627D1 (de) 1995-01-19
DE69105627T2 DE69105627T2 (de) 1995-04-20

Family

ID=27063388

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69105627T Expired - Fee Related DE69105627T2 (de) 1990-05-29 1991-05-29 Immunreagenzien reaktiv mit einem konservierten Epitope des humanen Immundefizienzviruses I (HIV-I) GP120 und Verfahren zu deren Verwendung.

Country Status (12)

Country Link
US (2) US6054284A (de)
EP (2) EP0459779B1 (de)
JP (1) JP2792733B2 (de)
AP (1) AP237A (de)
AT (1) ATE115189T1 (de)
AU (2) AU643285B2 (de)
DE (1) DE69105627T2 (de)
DK (1) DK0459779T3 (de)
ES (1) ES2067866T3 (de)
GR (1) GR3015269T3 (de)
OA (1) OA09499A (de)
WO (1) WO1991018928A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP237A (en) * 1990-05-29 1993-04-29 Cedars Sinai Medical Center Immunoreagents reactive with a conserved epitope of human immunodeficiency virus type 1 (HIV-1) gp120 and methods of use.
US5346989A (en) * 1990-08-22 1994-09-13 Syntello Vaccine Development Kb Peptides for use in induction of T cell activation against HIV-1
ES2194836T3 (es) * 1990-09-27 2003-12-01 Tripep Ab Peptidos para su uso en vacunacion e induccion de anticuerpos neutralizantes contra el virus de la inmunodeficiencia humana.
EP0554401A4 (en) * 1990-10-26 1996-10-30 New York Health Res Inst Neutralizing human monoclonal antibodies specific for the v3 loop and cd-4 binding site of hiv-1 gp120
EP0594638A1 (de) * 1991-06-03 1994-05-04 Syntello Vaccine Development Ab Peptide zur induktion der t-zell aktivierung gegen hiv-1
ATE405679T1 (de) 1993-10-19 2008-09-15 Scripps Research Inst Synthetische humane neutralisierende monoklonale antikörper gegen hiv
US6193982B1 (en) 1995-04-27 2001-02-27 The United States Of America As Represented By The Department Of Health & Human Services Anti-cyanovirin antibody with an internal image of gp120, a method of use thereof, and a method of using a cyanovirin to induce an immune response to gp120
US6428790B1 (en) 1995-04-27 2002-08-06 The United States Of America As Represented By The Secretary Department Of Health And Human Services Cyanovirin conjugates and matrix-anchored cyanovirin and related compositions and methods of use
US7048935B2 (en) 1995-04-27 2006-05-23 The United States Of America As Represented By The Department Of Health And Human Services Cyanovirin conjugates and matrix-anchored cyanovirin and related compositions and methods of use
US6987096B1 (en) 1995-04-27 2006-01-17 The United States Of America As Represented By The Department Of Health And Human Services Antiviral proteins and peptides, DNA coding sequences therefor, and uses thereof
US5843882A (en) 1995-04-27 1998-12-01 The United States Of America As Represented By The Department Of Health And Human Services Antiviral proteins and peptides
US6780847B2 (en) 1995-04-27 2004-08-24 The United States Of America As Represented By The Department Of Health And Human Services Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins
EP1141314A2 (de) 1998-12-31 2001-10-10 Chiron Corporation Für antigene polypeptide des hiv type c kodierende polynukleotide, entsprechende polypeptide und verwendungen davon
PT1141315E (pt) 1998-12-31 2008-05-05 Novartis Vaccines & Diagnostic Polipéptidos do envelope (env) de hiv modificados
JP2002533124A (ja) 1998-12-31 2002-10-08 カイロン コーポレイション Ｈｉｖポリペプチドの改善された発現およびウイルス様粒子の生成
CA2441287C (en) 2001-03-22 2014-06-10 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins
EP2412242A3 (de) 2001-07-05 2012-06-13 Novartis Vaccines and Diagnostics, Inc. Polypeptide vom HIV-Typ C codierende Polynucleotide, Polypeptide und deren Verwendung
US20030170614A1 (en) 2001-08-31 2003-09-11 Megede Jan Zur Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof
US20050014230A1 (en) * 2003-07-16 2005-01-20 Ccl Holding Co., Ltd. Preparation of fully human antibodies
EP2138195A3 (de) 2004-06-16 2010-07-21 Affinergy Inc. Grenzflächenbiomaterialien zur Förderung der Anhaftung von Zielanalyten
WO2007035930A2 (en) * 2005-09-22 2007-03-29 Prosci Incorporated Glycosylated polypeptides produced in yeast mutants and methods of use thereof
US20110212119A1 (en) * 2008-10-31 2011-09-01 Proteonova, Inc. Methods for making hiv vaccines and related compositions
WO2011119920A2 (en) 2010-03-25 2011-09-29 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
CA2832109C (en) 2011-06-10 2021-07-06 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
EP2568289A3 (de) 2011-09-12 2013-04-03 International AIDS Vaccine Initiative Immunselektion von rekombinantem vesikulärem Stomatitisvirus mit Expression von HIV-1-Proteinen durch Breitbandneutralisierungs-Antikörper
EP2586461A1 (de) 2011-10-27 2013-05-01 Christopher L. Parks Von einem eingehüllten Virus abgeleitete Virenpartikel
EP2679596B1 (de) 2012-06-27 2017-04-12 International Aids Vaccine Initiative HIV-1 Env-proteinvariante
US20150065381A1 (en) 2013-09-05 2015-03-05 International Aids Vaccine Initiative Methods of identifying novel hiv-1 immunogens
US10058604B2 (en) 2013-10-07 2018-08-28 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
EP3069730A3 (de) 2015-03-20 2017-03-15 International Aids Vaccine Initiative Lösliche hiv-1-hüllglykoproteintrimere
US9931394B2 (en) 2015-03-23 2018-04-03 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59116230A (ja) * 1982-11-29 1984-07-05 ベイロ−・カレツジ・オヴ・メデイスン ウイルス性感染因子に対する免疫応答を生起する抗−イデイオタイプ抗体
US4536479A (en) * 1983-03-22 1985-08-20 E. I. Du Pont De Nemours And Company Use of anti-idiotype antibodies in immunoassays
AU609447B2 (en) * 1987-02-19 1991-05-02 Nissin Shokuhin Kabushiki Kaisha Methods and materials for hiv detection and therapy
US5215913A (en) * 1987-11-30 1993-06-01 Roger Williams General Hospital IgG-1 human monoclonal antibody reactive with an HIV-1 antigen and methods of use
EP0349645A4 (en) * 1987-12-15 1991-11-27 Nippon Shokubai Kagaku Kogyo Co. Ltd. Photo-setting composition
WO1989005821A1 (en) * 1987-12-21 1989-06-29 Arch Development Corporation Hiv-related antigens and antibodies
DE68918867T2 (de) * 1988-09-13 1995-02-16 Chiron Corp Mutanten des hiv-1 Hüllproteins mit fehlenden hypervariabelen domänen.
CA2051107A1 (en) * 1989-04-25 1990-10-26 William N. Sun Antibodies specific for cd4-binding domain of hiv
CA2066607A1 (en) * 1989-09-22 1991-03-23 Thomas Kieber-Emmons Peptides associated with the cd4 binding region of gp120 and their methods of use
AP237A (en) * 1990-05-29 1993-04-29 Cedars Sinai Medical Center Immunoreagents reactive with a conserved epitope of human immunodeficiency virus type 1 (HIV-1) gp120 and methods of use.
US5798251A (en) * 1990-05-29 1998-08-25 Cedars-Sinai Medical Center Antibody and antibody derivative immunoreagents reactive with a conserved epitope of Human Immunodeficiency Virus Type 1 (HIV-1) gp 120
AU651113B2 (en) * 1990-06-18 1994-07-14 Abbott Laboratories HIV GP120 monoclonal antibodies
GB9013566D0 (en) * 1990-06-18 1990-08-08 Shell Int Research Process for producing gasoline components

Also Published As

Publication number Publication date
EP0459779B1 (de) 1994-12-07
GR3015269T3 (en) 1995-06-30
AU660574B2 (en) 1995-06-29
OA09499A (en) 1992-11-15
JPH05500818A (ja) 1993-02-18
JP2792733B2 (ja) 1998-09-03
US6190871B1 (en) 2001-02-20
AP237A (en) 1993-04-29
ATE115189T1 (de) 1994-12-15
AU5510794A (en) 1994-04-28
US6054284A (en) 2000-04-25
EP0459779A1 (de) 1991-12-04
WO1991018928A1 (en) 1991-12-12
DK0459779T3 (da) 1995-05-29
AP9100280A0 (en) 1991-07-31
EP0614985A1 (de) 1994-09-14
DE69105627T2 (de) 1995-04-20
ES2067866T3 (es) 1995-04-01
AU7803591A (en) 1991-12-05
AU643285B2 (en) 1993-11-11

Similar Documents

Publication Publication Date Title
DE69105627D1 (de) Immunreagenzien reaktiv mit einem konservierten Epitope des humanen Immundefizienzviruses I (HIV-I) GP120 und Verfahren zu deren Verwendung.
DE68921351D1 (de) Mit einem faserbündel verstärkter knochenzement sowie verfahren.
EP0554401A4 (en) Neutralizing human monoclonal antibodies specific for the v3 loop and cd-4 binding site of hiv-1 gp120
NZ220653A (en) Hiv env region peptides and d-retro versions thereof
DE4290049T1 (de) Verwendung eines Wachstumsfaktors in einer schlankmachenden Zubereitung
IT1222518B (it) Anticorpi monoclonali e peptidi utili a trattare e diagnosticare infezione da hiv
IL93927A0 (en) Replication competent human immunodeficiency type 2 proviral clone
DK488989A (da) Fremgangsmaade til behandling af en poroes anodisk aluminiumoxidmembran
NZ220803A (en) Composite immunogen consisting of t and b cell epitopes of hepatitis b surface antigen
DE3775952D1 (de) Gelenk- und unterarmgruppe eines roboters.
ES514536A0 (es) "metodo de fijacion industrial de cremalleras a tejidos de punto y similares".
DE68903191D1 (de) Gelenkverbindung nach art eines handgelenkes.
ZA913909B (en) Immunoreagents reactive with a conserved epitope of human immunodeficiency virus type i(hiv-1)gpl20 and methods of use
ATE127526T1 (de) Verfahren zur herstellung von natürlichem hiv- glykoprotein 160.
DE3889735D1 (de) Chemischer dampfniederschlagsreaktor und dessen verwendung.
ZA892907B (en) Peptides derived from human immunodeficiency virus-1 gp160
ZA87162B (en) Process for the prepartion of polyethylene objects having a high strength and a high modulus
DE69600374D1 (de) Zubereitung in Form von einer weichen Paste und Herstellungsverfahren
EP0402757A3 (de) Festphasenimmunoassay und Testbesteck zur Bestimmung von Antigenen und Antikörpern
DK0498905T3 (da) Tilpassede epitoper af human immundeficiensvirus kappeglycoprotein gp120
DE59101049D1 (de) Einrichtung zum transportieren eines scheinebündels oder dergleichen von einer sammelstation zu einer ausgabestation.
ATE108664T1 (de) Verfahren zur verhütung von gvhd.
IL89951A0 (en) A method of infecting animals with human immunodeficiency virus(hiv)
ATE209676T1 (de) Verwendung von mit herpesvirus saimiri transformierten lymphozyten in einem verfahren zur vermehrung von immunschwäche verursachenden viren vom hiv-typ
DK0726834T3 (da) En fremgangsmåde til fremstilling af sug til medicinsk og dental brug

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee